<DOC>
	<DOC>NCT00080496</DOC>
	<brief_summary>To compare the efficacy and safety of the tigecycline regimen with that of the imipenem/cilastatin regimen in subjects with nosocomial pneumonia.</brief_summary>
	<brief_title>Study Evaluating Tigecycline Versus Imipenem/Cilastatin in Hospital-Acquired Pneumonia</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia, Bacterial</mesh_term>
	<mesh_term>Imipenem</mesh_term>
	<mesh_term>Tigecycline</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<mesh_term>Cilastatin</mesh_term>
	<criteria>Male or female subjects over 18 years of age. Bulgaria Only: Male or female subjects over 18 years of age and under 70 years of age. Subjects known or suspected to have acute hospitalacquired pneumonia. Presence of any of the following pulmonary conditions: cystic fibrosis; pulmonary malignancy (either primary or metastatic); known bronchialobstructive or post obstructive pneumonia; pulmonary abscess; empyema; known or suspected active tuberculosis; bronchiectasis; sarcoidosis; known or suspected pulmonary infection caused by Pneumocystis carinii, mycobacteria, fungi, parasites, or viruses (Subjects with COPD are not excluded) Suspected or known Legionella infection Concurrent hemodialysis, hemofiltration, peritoneal dialysis, or plasmapheresis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Pneumonia</keyword>
</DOC>